Giuseppe Cappellano Selected Research

Giuseppe Cappellano Research Topics

Disease

9	COVID-19 01/2022 - 10/2020
7	Neoplasms (Cancer) 12/2021 - 05/2014
6	Multiple Sclerosis 06/2021 - 01/2012
6	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2012
4	Melanoma (Melanoma, Malignant) 12/2021 - 08/2019
4	Infections 01/2021 - 01/2012
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 09/2014
3	Neoplasm Metastasis (Metastasis) 12/2021 - 05/2014
3	Inflammation (Inflammations) 10/2021 - 01/2017
3	Atherosclerosis 01/2019 - 09/2015
2	Rheumatoid Arthritis 12/2021 - 01/2012
2	Lung Diseases (Lung Disease) 11/2021 - 01/2021
2	Alzheimer Disease (Alzheimer's Disease) 06/2021 - 01/2010
2	Autoimmune Lymphoproliferative Syndrome 02/2014 - 11/2006
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2013 - 11/2006
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Osteoarthritis 12/2021
1	Musculoskeletal Diseases (Musculoskeletal Disease) 12/2021
1	Wounds and Injuries (Trauma) 10/2021
1	Nervous System Diseases (Neurological Disorders) 06/2021
1	Disease Progression 01/2021
1	Experimental Melanoma 10/2020
1	Skin Neoplasms (Skin Cancer) 01/2020
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 10/2019
1	Cicatrix (Scar) 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Encephalomyelitis (Myeloencephalitis) 01/2018
1	Contracture 01/2018
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Splenomegaly 02/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2013

Drug/Important Bio-Agent (IBA)

12	OsteopontinIBA 12/2021 - 01/2010
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2020
6	CytokinesIBA 01/2020 - 01/2012
5	PerforinIBA 01/2017 - 11/2006
4	VaccinesIBA 06/2021 - 09/2015
3	LigandsIBA 12/2021 - 05/2014
3	Peptides (Polypeptides)IBA 06/2021 - 09/2014
3	AntigensIBA 01/2020 - 09/2014
2	ChemokinesIBA 10/2021 - 01/2020
2	Messenger RNA (mRNA)IBA 06/2021 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 11/2009
2	AntibodiesIBA 01/2021 - 01/2017
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 10/2020 - 09/2014
2	Death Domain ReceptorsIBA 02/2014 - 11/2006
2	Interleukin-17 (Interleukin 17)IBA 02/2014 - 01/2012
1	Biocompatible Materials (Biomaterials)IBA 12/2021
1	Chemotactic FactorsIBA 10/2021
1	Oxidants (Oxidizing Agents)IBA 10/2021
1	Hemostatics (Antihemorrhagics)IBA 10/2021
1	Liposomes (Liposome)IBA 06/2021
1	DNA (Deoxyribonucleic Acid)IBA 06/2021
1	InterferonsIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	MucinsIBA 01/2021
1	PorphyrinsIBA 11/2020
1	Transfer RNA (tRNA)IBA 11/2020
1	Tryptophan (L-Tryptophan)FDA Link 11/2020
1	Tricarboxylic AcidsIBA 11/2020
1	LipidsIBA 11/2020
1	Arachidonic Acid (Vitamin F)IBA 11/2020
1	Phospholipases A2 (Phospholipase A2)IBA 11/2020
1	Phenylalanine (L-Phenylalanine)FDA Link 11/2020
1	Tyrosine (L-Tyrosine)FDA Link 11/2020
1	Granzymes (Granzyme)IBA 01/2020
1	Imiquimod (Aldara)FDA LinkGeneric 01/2020
1	Apolipoproteins E (ApoE)IBA 01/2019
1	SiliconesIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018
1	LipopolysaccharidesIBA 01/2017
1	oxidized low density lipoproteinIBA 01/2017
1	Inosine Triphosphate (ITP)IBA 01/2017
1	Advanced Glycation End ProductsIBA 01/2017
1	Chaperonin 60IBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2016
1	AlkaloidsIBA 01/2016
1	Thrombin FDA Link 01/2016
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2016
1	CamptothecinIBA 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	CyclodextrinsIBA 01/2016
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2015
1	Pharmaceutical PreparationsIBA 05/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2014
1	EndocannabinoidsIBA 04/2013
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 04/2013
1	EnzymesIBA 04/2013
1	Protein Kinase CIBA 04/2013
1	Phosphotransferases (Kinase)IBA 04/2013

Therapy/Procedure

5	Therapeutics 12/2021 - 01/2012
2	Immunotherapy 01/2021 - 10/2020
1	Debridement 10/2021
1	Immunomodulation 01/2021
1	Breast Implants (Breast Implant) 01/2018
1	Injections 09/2014